Lead Plaintiff in Canadian Right To Try Lawsuit Shares His Psilocybin Story
Advocates Push for California Psychedelic Decrim Bill to Reach Crucial Vote
Remembering Ann Shulgin and What She Taught Us About the Shadow 
Ann Shulgin, Forerunner of Today’s Psychedelic Reemergence, Dies at 91 
Can Psychedelics Treat Inflammation and Eye Disease? Eleusis Thinks So.
Dennis McKenna Extolls Our Deepening Knowledge of Psychoactive Plants
Scholars, Mystics and Activists Explore the Profound Awareness of Plants
The Elephant in the Room is LSD
NFTs Are Getting Psychedelic. Is It Worth the Trip?
Connecticut Cites FDA Program to Launch Psychedelic Therapy Pilot
Psychedelic Therapy Training Programs Expand To Meet Demand
Journey Colab Looks to Mescaline for Treating Alcohol Use Disorder
Meditation Meets VR in Fujii’s Trippy Garden
Protests at DEA for Medical Psilocybin Lead to Arrests
Oregon Issues Draft of Magic Mushroom Cultivation Rules